AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Peters-Engl, C Frank, W Kerschbaum, F Denison, U Medl, M Sevelda, P
Citation: C. Peters-engl et al., Lunar phases and survival of breast cancer patients - a statistical analysis of 3,757 cases, BREAST CANC, 70(2), 2001, pp. 131-135

Authors: Obermair, A Geramou, M Gucer, F Denison, U Graf, AH Kapshammer, E Medl, M Rosen, A Wierrani, F Neunteufel, W Frech, I Preyer, O Speiser, P Kainz, C
Citation: A. Obermair et al., Impact of hysteroscopy on disease-free survival in clinically stage I endometrial cancer patients, INT J GYN C, 10(4), 2000, pp. 275-279

Authors: Huber, S Danes, J Zuna, I Teubner, J Medl, M Delorme, S
Citation: S. Huber et al., Relevance of sonographic B-mode criteria and computer-aided ultrasonic tissue characterization in differential/diagnosis of solid breast masses, ULTRASOUN M, 26(8), 2000, pp. 1243-1252

Authors: Huber, S Medl, M Helbich, T Taucher, S Wagner, T Rudas, M Zuna, I Delorme, S
Citation: S. Huber et al., Locally advanced breast carcinoma: Computer assisted semiquantitative analysis of color Doppler ultrasonography in the evaluation of tumor response to neoadjuvant chemotherapy (work in progress), J ULTR MED, 19(9), 2000, pp. 601-607

Authors: Huber, S Medl, M Vesely, M Czembirek, H Zuna, I Delorme, S
Citation: S. Huber et al., Ultrasonographic tissue characterization in monitoring tumor response to neoadjuvant chemotherapy in locally advanced breast cancer (work in progress), J ULTR MED, 19(10), 2000, pp. 677-686

Authors: Medl, M Peters-Engl, C Schutz, P Vesely, M Sevelda, P
Citation: M. Medl et al., First report of lymphatic mapping with isosulfan blue dye and sentinel node biopsy in cervical cancer, ANTICANC R, 20(2B), 2000, pp. 1133-1134

Authors: Huber, S Wagner, M Zuna, I Medl, M Czembirek, H Delorme, S
Citation: S. Huber et al., Locally advanced breast carcinoma: Evaluation of mammography in the prediction of residual disease after induction chemotherapy, ANTICANC R, 20(1B), 2000, pp. 553-558

Authors: Dobianer, K Medl, M Spona, J
Citation: K. Dobianer et al., Quantitative PCR detection of c-erbB-2 gene amplification, METH MOL M, 39, 2000, pp. 389-395

Authors: Obermair, A Geramou, M Gucer, F Denison, U Graf, AH Kapshammer, E Medl, M Rosen, A Wierrani, F Neunteufel, W Frech, I Speiser, P Kainz, C Breitenecker, G
Citation: A. Obermair et al., Endometrial cancer: accuracy of the finding of a well differentiated tumorat dilatation and curettage compared to the findings at subsequent hysterectomy, INT J GYN C, 9(5), 1999, pp. 383-386

Authors: Peters-Engl, C Frank, W Danmayr, E Friedl, HP Leodolter, S Medl, M
Citation: C. Peters-engl et al., Association between endometrial cancer and tamoxifen treatment of breast cancer, BREAST CANC, 54(3), 1999, pp. 255-260

Authors: Peters-Engl, C Frank, W Leodolter, S Medl, M
Citation: C. Peters-engl et al., Tumor flow in malignant breast tumors measured by Doppler ultrasound: an independent predictor of survival, BREAST CANC, 54(1), 1999, pp. 65-71

Authors: Peters-Engl, C Obermair, A Heinzl, H Buxbaum, P Sevelda, P Medl, M
Citation: C. Peters-engl et al., CA 125 regression after two completed cycles of chemotherapy: lack of prediction for long-term survival in patients with advanced ovarian cancer, BR J CANC, 81(4), 1999, pp. 662-666

Authors: Peters-Engl, C Buxbaum, P Ogris, E Sevelda, P Medl, M
Citation: C. Peters-engl et al., TATI (tumor associated trypsin inhibitor) and cancer antigen 125 (CA 125) in patients with early-stage endometrial cancer, ANTICANC R, 18(6B), 1998, pp. 4635-4639
Risultati: 1-13 |